Etiology of Parkinson's disease

被引:165
作者
Schapira, Anthony H. V.
机构
[1] UCL, Univ Dept Clin Neurosci, Royal Free & Univ Coll Med Sch, London NW3 2PF, England
[2] UCL, Inst Neurol, London NW3 2PF, England
基金
英国惠康基金;
关键词
D O I
10.1212/WNL.66.10_suppl_4.S10
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The etiology of Parkinson's disease (PD) has long been thought to involve both genetic and environmental factors, but until recently there has been no direct evidence to support either one as a causative factor. However, in the past 8 years six different genes have been identified as causing familial PD. Together, they support the notion that common pathogenetic mechanisms exist across the etiologic spectrum of PD. Specifically, mutations in alpha-synuclein, parkin, UCHL1, DJ1, PINK1, and LRRK2 cause PD, with a Mendelian pattern of inheritance. DJ1 and PINK1 are mitochondrial proteins and overexpression of a-synuclein and parkin induce mitochondrial defects. These same proteins are involved in the response to oxidative stress and affect proteasomal function. In contrast, few environmental factors have been characterized. Nevertheless, those toxins that have been demonstrated to have the ability to cause nigrostriatal cell death appear to interact by interfering with mitochondrial function, inducing oxidative stress, and modifying proteasomal function. Therefore, common themes are beginning to emerge in the etiopathogenesis of PD. This bodes well for research focused on the development of treatments that will modify the course of PD.
引用
收藏
页码:S10 / S23
页数:14
相关论文
共 142 条
[21]   Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct [J].
Conway, KA ;
Rochet, JC ;
Bieganski, RM ;
Lansbury, PT .
SCIENCE, 2001, 294 (5545) :1346-1349
[22]   1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) NEUROTOXICITY IN MICE IS ENHANCED BY PRETREATMENT WITH DIETHYLDITHIOCARBAMATE [J].
CORSINI, GU ;
PINTUS, S ;
CHIUEH, CC ;
WEISS, JF ;
KOPIN, IJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 119 (1-2) :127-128
[23]   Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death [J].
Darios, F ;
Corti, O ;
Lücking, CB ;
Hampe, C ;
Muriel, MP ;
Abbas, N ;
Gu, WJ ;
Hirsch, EC ;
Rooney, T ;
Ruberg, M ;
Brice, A .
HUMAN MOLECULAR GENETICS, 2003, 12 (05) :517-526
[24]   Environmental and genetic risk factors in Parkinson's disease: A case-control study in southern Italy [J].
DeMichele, G ;
Filla, A ;
Volpe, G ;
DeMarco, V ;
Gogliettino, A ;
Ambrosio, G ;
Marconi, R ;
Castellano, AE ;
Campanella, G .
MOVEMENT DISORDERS, 1996, 11 (01) :17-23
[25]   Genetic and clinical identification of Parkinson's disease patients with LRRK2 G2019S mutation [J].
Deng, H ;
Le, WD ;
Guo, Y ;
Hunter, CB ;
Xie, WJ ;
Jankovic, J .
ANNALS OF NEUROLOGY, 2005, 57 (06) :933-934
[26]   Genome-wide scan for Parkinson's disease:: The GenePD study [J].
DeStefano, AL ;
Golbe, LI ;
Mark, MH ;
Lazzarini, AM ;
Maher, NE ;
Saint-Hilaire, M ;
Feldman, RG ;
Guttman, M ;
Watts, RL ;
Suchowersky, O ;
Lafontaine, AL ;
Labelle, N ;
Lew, MF ;
Waters, CH ;
Growdon, JH ;
Singer, C ;
Currie, LJ ;
Wooten, GF ;
Vieregge, P ;
Pramstaller, PP ;
Klein, C ;
Hubble, JP ;
Stacy, M ;
Montgomery, E ;
MacDonald, ME ;
Gusella, JF ;
Myers, RH .
NEUROLOGY, 2001, 57 (06) :1124-1126
[27]  
Di Fonzo A, 2005, LANCET, V365, P412
[28]   Pyrethroid pesticide-induced alterations in dopamine transporter function [J].
Elwan, MA ;
Richardson, JR ;
Guillot, TS ;
Caudle, WM ;
Miller, GW .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2006, 211 (03) :188-197
[29]  
Fall PA, 1999, MOVEMENT DISORD, V14, P28, DOI 10.1002/1531-8257(199901)14:1&lt
[30]  
28::AID-MDS1007&gt